AiLife Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- AiLife Diagnostics's estimated annual revenue is currently $1.9M per year.
- AiLife Diagnostics's estimated revenue per employee is $155,000
Employee Data
- AiLife Diagnostics has 12 Employees.
- AiLife Diagnostics grew their employee count by 9% last year.
AiLife Diagnostics's People
Name | Title | Email/Phone |
---|---|---|
1 | Clinical Bioinformatics Manager | Reveal Email/Phone |
AiLife Diagnostics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is AiLife Diagnostics?
AiLife Diagnostics, Inc. was founded by people with many years of experience in genomic medicine. The company now includes a group of experts in genome medicine, bioinformatics, qualify management, customer services, and finance. We have developed NGS analysis tools including 1) Annotation of Genes and Proteins Systematically (A-GPSTM); 2) Interpretation of Genes and Proteins Systematically (I-GPSTM); 3) Discovery of Genes with Possible disease contributions Systematically (D-GPSTM). These tools can greatly facilitate the analysis, interpretation, and research mining of NGS data. Our goal is to empower the medical community by providing comprehensive genetic data analyses and interpretations through innovation, research, and education.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 13 | N/A | N/A |
#2 | $1.6M | 13 | 0% | N/A |
#3 | $1.2M | 14 | 0% | N/A |
#4 | $1.3M | 15 | 7% | N/A |
#5 | $2M | 16 | -16% | N/A |